141 related articles for article (PubMed ID: 3630929)
1. Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris.
Thadani U; Prasad R; Hamilton SF; Voyles W; Doyle R; Karpow S; Reder R; Teague SM
Am J Cardiol; 1987 Sep; 60(7):477-82. PubMed ID: 3630929
[TBL] [Abstract][Full Text] [Related]
2. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
Thadani U; Hamilton SF; Olson E; Anderson JL; Prasad R; Voyles W; Doyle R; Kirsten E; Teague SM
Am J Cardiol; 1987 Apr; 59(8):756-62. PubMed ID: 3825935
[TBL] [Abstract][Full Text] [Related]
3. Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
Thadani U; Prasad R; Hamilton SF; Voyles WF; Doyle R; Karpow SA; Reder R; Teague SM
Clin Pharmacol Ther; 1987 Jul; 42(1):58-65. PubMed ID: 3595067
[TBL] [Abstract][Full Text] [Related]
4. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
[TBL] [Abstract][Full Text] [Related]
5. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
Thadani U; Bittar N
Am J Cardiol; 1992 Aug; 70(3):286-92. PubMed ID: 1632390
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
8. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
Thadani U; Fung HL; Darke AC; Parker JO
Am J Cardiol; 1982 Feb; 49(2):411-9. PubMed ID: 7058754
[TBL] [Abstract][Full Text] [Related]
9. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
Nordlander R; Walter M
Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
[TBL] [Abstract][Full Text] [Related]
10. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
Hughes LO; DasGupta P; Jain D; Lahiri A; Raftery EB
Eur J Clin Pharmacol; 1989; 36(2):139-44. PubMed ID: 2498105
[TBL] [Abstract][Full Text] [Related]
12. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of isosorbide mononitrate in angina pectoris.
Thadani U; de Vane PJ
Am J Cardiol; 1992 Nov; 70(17):67G-71G. PubMed ID: 1449103
[TBL] [Abstract][Full Text] [Related]
14. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
15. The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate.
Bassan MM
J Am Coll Cardiol; 1990 Oct; 16(4):936-40. PubMed ID: 2212374
[TBL] [Abstract][Full Text] [Related]
16. Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris.
Wisenberg G; Roks C; Nichol P; Goddard MD
Am J Cardiol; 1989 Sep; 64(10):569-76. PubMed ID: 2782247
[TBL] [Abstract][Full Text] [Related]
17. Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.
Parker JO
Am J Cardiol; 1993 Oct; 72(12):871-6. PubMed ID: 8213541
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
[TBL] [Abstract][Full Text] [Related]
20. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Gunasekara NS; Noble S
Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]